Ferdinand Verdonck

President chez Dellacorte Acquisition Corp.

Profil

Ferdinand L.
J.
Verdonck currently works at The Phoenix Funds, as Director from 2013, Laco Information Services, as Director, Dellacorte Acquisition Corp., as President, and Affimed GmbH, as Member-Supervisory Board from 2014.
Mr. Verdonck also formerly worked at EASDAQ NV, as Chairman, Amsterdam Molecular Therapeutics (AMT) Holding NV, as Chairman-Supervisory Board from 2010 to 2013, Nasdaq Europe Planning Co. Ltd., as Chairman, uniQure NV, as Chairman-Supervisory Board from 2013 to 2016, Phoenix Investment Partners Ltd., as Director, Dictaphone Corp., as Director, Galapagos NV, as Independent Non-Executive Director from 2005 to 2013, Almanij NV, as Managing Director from 1992 to 2003, JPMorgan European Investment Trust Plc Growth Shares, as Independent Non-Executive Director from 2012 to 2015, Banco Urquijo Sabadell Banca Privada SA, as Director from 2009 to 2010, SNEF SA, as Director, Movetis NV, as Director, Immo Santens Metaalwaren BV, as Director, Nederlandse Kamer van Koophandel voor België en Luxemburg, as Director, Lazard Frères & Co. LLC, as Senior Vice President, Affimed NV, as Independent Member-Supervisory Board from 2014 to 2021, Bekaert SA, as Chief Financial Officer-WorldWide Group from 1984 to 1992, Vlerick Leuven Gent Management School, as Member-General Council, and Virtus Total Return Fund, as Independent Trustee.
Mr. Verdonck received his undergraduate degree from The University of Chicago and undergraduate degree and graduate degree from Katholieke Universiteit Leuven.

Postes actifs de Ferdinand Verdonck

Sociétés	Poste	Début
Dellacorte Acquisition Corp.	President	-
Laco Information Services	Directeur/Membre du Conseil	-
The Phoenix Funds	Directeur/Membre du Conseil	13/11/2013
Affimed GmbH	Directeur/Membre du Conseil	01/07/2014

Anciens postes connus de Ferdinand Verdonck

Sociétés	Poste	Fin
AFFIMED N.V.	Directeur/Membre du Conseil	14/06/2021
UNIQURE N.V.	Président	15/06/2016
JPMorgan European Investment Trust Plc Growth Shares	Directeur/Membre du Conseil	21/07/2015
Amsterdam Molecular Therapeutics (AMT) Holding NV	Président	11/03/2013
LAKEFRONT BIOTHERAPEUTICS NV	Directeur/Membre du Conseil	04/03/2013